Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab
D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic
D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates
D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results
D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center
D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
D2.33 - Correlation of chronic rhinosinusitis and lung function in allergy patients with chronic cough
D2.34 - Generalized allergic contact dermatitis: a case report
D2.35 - Prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR), based on skin prick test (SPT) and its seasonal variation
D2.36 - Clinical Outcomes Of Dental Procedures In Patients With Hereditary Angioedema
D2.37 - Prevalence of food cross-sensitization due to PR-10 proteins among patients of different age groups
D2.38 - Clinical Evaluation of Alternaria alternata Extract Used for Skin Prick Test in Diagnosis of Alternaria alternata Allergy
D2.39 - Diagnostic performance of IgE sensitization with Blomia tropicalis for prediction of positive nasal challenge test
D2.42 - Clinical relevance of secondary sensitizations to indoor allergens in patients with persistent allergic rhinitis in a region with high prevalence of dust mite allergy
D2.43 - Implementation of the New Italian Health Care Price List: Impact on Allergy Diagnostics
D2.44 - Kiwi Allergy in Singaporean Children
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download